This document was prepared for ASRA by Hart Health Strategies Inc., December 2020

The Medicare Access and CHIP Reauthorization Act (MACRA) was signed into law April 2015, repealing the flawed sustainable growth rate (SGR) and establishing a two-track Quality Payment Program (QPP) that emphasizes Medicare’s transition to value-based payment and delivery. Under the QPP, eligible pain medicine practitioners will either participate in the Merit-based Incentive Payment System (MIPS) or be considered a qualifying participant in an Advanced Alternative Payment Model (APM). With the QPP moving into its fifth year – the 2021 performance period – pain medicine practitioners should note important changes that impact participation.

Read full document (PDF)